You are here

diabetes

No Matter What The FDA Decides, New Diabetes Drugs Will Still Require CV Outcomes Trials

Forbes

Tue, 11/6/18 - 09:46 am

cardiovascular outcomes

Eli Lilly touts MACE win for diabetes blockbuster Trulicity — a 'nice positive'

Endpoints

Mon, 11/5/18 - 11:54 am

Amazon eyes chronic health market with Arcadia Group’s Choice health brand launch

Mass Device

Mon, 10/29/18 - 07:18 pm

FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review

CP Wire

Tue, 10/23/18 - 10:22 am

Xeris Pharmaceuticals

FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review

Tue, 10/23/18 - 09:25 am

Xeris Pharmaceuticals

Abbott CEO on Libre: ‘We’re just getting started’

Drug Delivery Business News

Thu, 10/18/18 - 11:25 am

FreeStyle Libre

blood glucose monitoring

Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices

Biopharma Dive

Thu, 10/18/18 - 12:12 am

FDA’s OPDP Warns MannKind for Facebook Post

RAPS.org

Tue, 10/16/18 - 11:52 pm

Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?

Fierce Pharma

Fri, 10/12/18 - 12:47 pm

Samsung Bioepis

New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease

CP Wire

Wed, 10/10/18 - 10:13 am

Boehringer Ingelheim

type 2 diabetes

Lilly makes waves with next-generation diabetes drug, but GLP-1 rivals needn't panic: analysts

Fierce Pharma

Mon, 10/8/18 - 11:03 pm

Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?

Fierce Pharma

Fri, 10/5/18 - 08:51 pm

Boehringer Ingelheim

Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results

Endpoints

Thu, 10/4/18 - 11:58 am

Eli Lilly's diabetes treatment meets main goal in two late-stage studies

Reuters

Tue, 10/2/18 - 10:54 pm

Ultra Rapid Lispro

type 1 diabetes

type 2 diabetes

Novo to market ‘connected’ insulin pens next year

Pharmaforum

Tue, 10/2/18 - 09:53 am

connected insulin pen

Dance Biopharm raises $24m for inhaled insulin device

Drug Delivery Business News

Tue, 09/25/18 - 07:34 pm

inhaled insulin

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy

Xconomy

Mon, 09/17/18 - 03:18 pm

CRISPR Therapeutics

Livongo and Abbott Take Diabetes Management to New Heights

Medical Devices and Diagnostics Industry

Sat, 09/8/18 - 11:48 pm

FreeStyle Libre

Mellitus Health, Smart Meter ink connected insulin titration deal

Drug Delivery Business News

Fri, 09/7/18 - 06:16 pm

Mellitus Health

insulin titration

Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong

Pharmaforum

Mon, 09/3/18 - 12:11 pm

Pages